Showing results for

Life Sciences and HealthcareRemove

Publication

Analysis of China's New Regulations for Human Genetic Resources

Analysis of China's New Regulations for Human Genetic Resources

By | 28 Aug 2019

This article, the first in a series, provides an insight of the new measures adopted in the Administration Regulations on Human Genetic Resources which were formally implemented on July 1, 2019.

Publication

Privacy implications of AI-powered medical devices

Privacy implications of AI-powered medical devices

By , and | 18 Mar 2019

Confidentiality is an important legal and ethical duty in the UK health sector, but the potential of artificial intelligence to improve patient care has raised some thorny questions about how medical information is used to best effect, while remaining GDPR-compliant.

Publication

L'agence française du médicament (ANSM) prend une sanction financière majeure de près de 350.000 euros contre un industriel

L'agence française du médicament (ANSM) prend une sanction financière majeure de près de 350.000 euros contre un industriel

By , , and | 21 Jan 2019

The French Medicines Agency (ANSM) imposes a major financial penalty of nearly 350,000 euros on a pharmaceutical company

Publication

Junior market detractors should AIM criticisms elsewhere

Junior market detractors should AIM criticisms elsewhere

By and | 14 Jan 2019

Fieldfisher responds to article in the Sunday Times regarding the number of AIM-listed company insolvencies in 2018.

Publication

Dirty laundry: Do British businesses risk being tarnished by new EU anti-money laundering rules post-Brexit?

Dirty laundry: Do British businesses risk being tarnished by new EU anti-money laundering rules post-Brexit?

By and | 05 Oct 2018

Fieldfisher corporate crime partner Francesca Titus and corporate crime associate Elliott Kenton discuss how moves to tighten up EU AML legislation could side-line UK companies.

Publication

Nouvelles méthodologies de référence publiées par la CNIL : quel impact sur les notes d'information à délivrer aux patients dans le cadre des essais cliniques ?

Nouvelles méthodologies de référence publiées par la CNIL : quel impact sur les notes d'information à délivrer aux patients dans le cadre des essais cliniques ?

By and | 19 Jul 2018

New reference documents published by the French data protection authority (CNIL): what impact on information notes to be delivered to patients in clinical trials?

Publication

Le Conseil d'Etat se prononce en faveur d'une plus grande communication des professionnels de santé à destination du public : quel en sera l'impact pour les industriels du secteur ?

Le Conseil d'Etat se prononce en faveur d'une plus grande communication des professionnels de santé à destination du public : quel en sera l'impact pour les industriels du secteur ?

By and | 02 Jul 2018

The Conseil d'Etat is in favour of greater communication by healthcare professionals to the public: what impact will this have on manufacturers in the sector?

Publication

Infraction à la loi "anti-cadeaux" : la Cour de cassation confirme l'arrêt de la cour d'appel de Paris ayant prononcé l'an dernier des amendes records

Infraction à la loi "anti-cadeaux" : la Cour de cassation confirme l'arrêt de la cour d'appel de Paris ayant prononcé l'an dernier des amendes records

By and | 12 Jun 2018

Violation of the "anti-kickback" statute: the French Supreme Court upholds the 2017 decision of the Paris Court of Appeal imposing record fines